- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07703592
Comparison of Manual PAOP and Automatic PAOP (Smart Wedge) (SMART-PAPO)
July 16, 2026 updated by: Assistance Publique - Hôpitaux de Paris
Comparison of Pulmonary Artery Occlusion Pressure (PAOP) Measurements Performed by an Expert Versus Those Obtained Using the SmartWedge Algorithm in Patients Undergoing Pulmonary Artery Catheterization (Swan-Ganz IQ™).
The pulmonary artery catheter (Swan-Ganz) is a standard tool in intensive care for measuring and monitoring the pulmonary artery occlusion pressure (PAOP).
The Swan-Ganz IQ™ model also allows automatic measurement to reduce the risk of error (Smart Wedge).
However, the concordance between this automatic method and the manual method remains poorly studied in real clinical conditions and may vary depending on certain clinical situations.
This study therefore aims to compare the PAOP automatically measured (Smart Wedge) with the manual PAOP measurement at bedside based on data collected in clinical practice.
Study Overview
Status
Not yet recruiting
Conditions
Intervention / Treatment
Detailed Description
The pulmonary artery catheter (or Swan-Ganz catheter) is a standard tool for measuring and monitoring PAOP in intensive care.
It measures PAOP manually, which is considered the gold standard method.
The Swan-Ganz IQ™ model also offers automatic measurement of PAOP during inflation of the balloon in the pulmonary artery (Smart Wedge).
The ability to automatically measure PAOP would decrease the risk of error.
However, the concordance between manual PAOP (reference method) and automatic PAOP (Smart Wedge) remains poorly evaluated by independent data in real clinical conditions.
Furthermore, this agreement may vary depending on the clinical situation.
In this context, this study aims to compare the manual PAOP measurement and the automatic PAOP measurement (Smart Wedge) based on data collected in the clinical setting.
Study Type
Observational
Enrollment (Estimated)
30
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Xavier MONNET
- Phone Number: 0145213539
- Email: xavier.monnet@aphp.fr
Study Contact Backup
- Name: Nicolas FAGE
- Email: nicolas.fage@aphp.fr
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Sampling Method
Non-Probability Sample
Study Population
Patients hospitalized in medical ICU (of Bicêtre and Angers) with pulmonary arterial catheter (PAC) place as part of routine clinical care.
Description
Inclusion Criteria:
- Age ≥18 years;
- Admission to an intensive care unit;
- Presence of a Swan-Ganz IQ™ pulmonary artery catheter placed as part of patient care;
- Measurement of pulmonary artery occlusion pressure (PAOP) performed by the attending clinician as part of patient care.
Exclusion Criteria:
- Pregnancy;
- Court-ordered protective measures.
- Refusal to participate by the patient's family members or the patient themselves.
- Cardiac output measurements by thermodilution or by continuous cardiac output analysis that cannot be interpreted.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Assess the agreement between PAOP values measured by the "Smart Wedge" algorithm and PAOP values analyzed by an expert in patients in shock who are being monitored via a pulmonary artery catheter (Swan Ganz IQ)
Time Frame: 1 day
|
The concordance between manual PAOP and automatic PAOP (assessed by the SmartWedge algorithm during the inflation of the ballon in the arterial pulmonary).
|
1 day
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Identify situations where there is a risk of discrepancy in the "Smart Wedge" value
Time Frame: 1 day
|
Identify situations where there is a risk of discrepancy in the "Smart Wedge" value: mechanical ventilation vs. spontaneous ventilation, high auto-PEEP, mitral regurgitation, arrhythmia.
|
1 day
|
|
Assess the variability between PAOP values measured by the Smart Wedge algorithm and those measured by an expert.
Time Frame: 1 day
|
Describe the variation and the relationship between the PAOP values measured by the "Smart Wedge" algorithm and those determined by expert interpretation.
|
1 day
|
|
Assess the agreement between the PAPO value provided by the "Smart Wedge" algorithm and the PAPO value used in clinical practice, and compare it to the agreement observed between the algorithm and the expert interpretation performed retrospectively.
Time Frame: 1 day
|
Evaluate the agreement between the PAPO value provided by the "Smart Wedge" algorithm and the PAPO value used in clinical practice at the patient's bedside (as recorded in the medical record by the attending clinician), and compare this agreement to that observed between the algorithm and the expert reading performed retrospectively.
|
1 day
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Study Director: Xavier MONNET, Assistance Publique - Hôpitaux de Paris
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Estimated)
July 10, 2026
Primary Completion (Estimated)
July 10, 2028
Study Completion (Estimated)
July 10, 2028
Study Registration Dates
First Submitted
July 8, 2026
First Submitted That Met QC Criteria
July 8, 2026
First Posted (Actual)
July 14, 2026
Study Record Updates
Last Update Posted (Actual)
July 17, 2026
Last Update Submitted That Met QC Criteria
July 16, 2026
Last Verified
June 1, 2026
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- SMART-PAPO
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Septic Shock
-
German Center for Neurodegenerative Diseases (DZNE)University Hospital, BonnUnknownSevere Sepsis With Septic Shock | Severe Sepsis Without Septic ShockGermany
-
Artcline GmbHRecruitingSepsis | Septic Shock | Immunoparalysis in Septic ShockGermany
-
Assistance Publique - Hôpitaux de ParisCompletedSeptic Shock HyperdynamicFrance
-
University of ZurichCompletedPatients in Septic ShockSwitzerland
-
Laiba QamarRecruitingSeptic Shock | Fluid Refractory Septic ShockPakistan
-
University Medicine GreifswaldUnknownSepsis Septic ShockGermany
-
Indonesia UniversityCompletedSevere Sepsis With Septic Shock | Severe Sepsis Without Septic ShockIndonesia
-
National Taiwan University HospitalBaxter Healthcare CorporationRecruiting
-
Charite University, Berlin, GermanyCompleted
-
University Hospital, GrenobleCompletedImmunocompetent Patient on Septic ShockFrance
Clinical Trials on Swan-Ganz IQ™, Smart Wedge
-
Bach Mai HospitalHanoi Medical UniversityRecruitingHemodynamic Monitoring | Cardiogenic Shock | Emergency | Acute Myocardial Infarction (AMI) | Critical Care, Intensive Care | Cardio Vascular Disease | Hemodynamic Optimization | Hemodynamic Management | Pulmonary Artery Catheter Waveform InterpretationVietnam
-
Becton, Dickinson and CompanyActive, not recruiting